ARTIS DEAN RICHARD 4
4 · Annexon, Inc. · Filed Feb 20, 2026
Research Summary
AI-generated summary of this filing
Annexon (ANNX) EVP Artis Dean Richard Sells 5,290 Shares
What Happened
Artis Dean Richard, Annexon’s EVP and Chief Scientific Officer, sold 5,290 shares in an open-market transaction on 2026-02-18. The weighted-average sale price was $5.10 per share (range $4.925–$5.155), for total proceeds of approximately $26,979. This was a sale (not a purchase).
Key Details
- Transaction date: 2026-02-18 (reported on Form 4 filed 2026-02-20). No late filing indicated.
- Transaction type/code: Sale (S). Executed in multiple trades at prices between $4.925 and $5.155; reported price is weighted average $5.10.
- Reason given (Footnote F1): Shares were sold to cover tax withholding obligations related to the vesting of restricted stock units (RSUs).
- Shares owned after transaction: Not disclosed in the provided filing details.
- Footnote F2: Reporting person will provide details of the number of shares sold at each price on request.
Context
Sales to cover tax withholding on vested RSUs are common and typically routine; they do not necessarily signal a change in insider sentiment about the company. This was a disposition to meet tax obligations rather than an opportunistic open-market purchase.
Insider Transaction Report
Form 4
Annexon, Inc.ANNX
ARTIS DEAN RICHARD
EVP & CHIEF SCIENTIFIC OFFICER
Transactions
- Sale
Common Stock
[F1][F2]2026-02-18$5.10/sh−5,290$26,979→ 123,487 total
Footnotes (2)
- [F1]The shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs").
- [F2]This transaction was executed in multiple trades in prices ranging from $4.925 to $5.155, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
Signature
/s/ Jennifer Lew, Attorney-in-Fact|2026-02-20